P788: OUTCOME OF SEVERE APLASTIC ANEMIA TREATED WITH ALLOGENIC STEM CELL TRANSPLANTATION COMPARED WITH IMMUNOSUPPRESSIVE THERAPY AS FIRST LINE.

Detalles Bibliográficos
Autores principales: Haroon, Alfadil, El Fakih, Riad, Aljurf, Mahmoud, Isam Sharif, Mohammed, Elhassan, Tusneem, Alzahrani, Hazzaa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
Posters
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10430514/
http://dx.doi.org/10.1097/01.HS9.0000970056.73977.c2
_version_ 1785090982282264576
author Haroon, Alfadil
El Fakih, Riad
Aljurf, Mahmoud
Isam Sharif, Mohammed
Elhassan, Tusneem
Alzahrani, Hazzaa
author_facet Haroon, Alfadil
El Fakih, Riad
Aljurf, Mahmoud
Isam Sharif, Mohammed
Elhassan, Tusneem
Alzahrani, Hazzaa
author_sort Haroon, Alfadil
collection PubMed
description
format Online
Article
Text
id pubmed-10430514
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-104305142023-08-17 P788: OUTCOME OF SEVERE APLASTIC ANEMIA TREATED WITH ALLOGENIC STEM CELL TRANSPLANTATION COMPARED WITH IMMUNOSUPPRESSIVE THERAPY AS FIRST LINE. Haroon, Alfadil El Fakih, Riad Aljurf, Mahmoud Isam Sharif, Mohammed Elhassan, Tusneem Alzahrani, Hazzaa Hemasphere Posters Lippincott Williams & Wilkins 2023-08-08 /pmc/articles/PMC10430514/ http://dx.doi.org/10.1097/01.HS9.0000970056.73977.c2 Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially.
spellingShingle Posters
Haroon, Alfadil
El Fakih, Riad
Aljurf, Mahmoud
Isam Sharif, Mohammed
Elhassan, Tusneem
Alzahrani, Hazzaa
P788: OUTCOME OF SEVERE APLASTIC ANEMIA TREATED WITH ALLOGENIC STEM CELL TRANSPLANTATION COMPARED WITH IMMUNOSUPPRESSIVE THERAPY AS FIRST LINE.
title P788: OUTCOME OF SEVERE APLASTIC ANEMIA TREATED WITH ALLOGENIC STEM CELL TRANSPLANTATION COMPARED WITH IMMUNOSUPPRESSIVE THERAPY AS FIRST LINE.
title_full P788: OUTCOME OF SEVERE APLASTIC ANEMIA TREATED WITH ALLOGENIC STEM CELL TRANSPLANTATION COMPARED WITH IMMUNOSUPPRESSIVE THERAPY AS FIRST LINE.
title_fullStr P788: OUTCOME OF SEVERE APLASTIC ANEMIA TREATED WITH ALLOGENIC STEM CELL TRANSPLANTATION COMPARED WITH IMMUNOSUPPRESSIVE THERAPY AS FIRST LINE.
title_full_unstemmed P788: OUTCOME OF SEVERE APLASTIC ANEMIA TREATED WITH ALLOGENIC STEM CELL TRANSPLANTATION COMPARED WITH IMMUNOSUPPRESSIVE THERAPY AS FIRST LINE.
title_short P788: OUTCOME OF SEVERE APLASTIC ANEMIA TREATED WITH ALLOGENIC STEM CELL TRANSPLANTATION COMPARED WITH IMMUNOSUPPRESSIVE THERAPY AS FIRST LINE.
title_sort p788: outcome of severe aplastic anemia treated with allogenic stem cell transplantation compared with immunosuppressive therapy as first line.
topic Posters
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10430514/
http://dx.doi.org/10.1097/01.HS9.0000970056.73977.c2
work_keys_str_mv AT haroonalfadil p788outcomeofsevereaplasticanemiatreatedwithallogenicstemcelltransplantationcomparedwithimmunosuppressivetherapyasfirstline
AT elfakihriad p788outcomeofsevereaplasticanemiatreatedwithallogenicstemcelltransplantationcomparedwithimmunosuppressivetherapyasfirstline
AT aljurfmahmoud p788outcomeofsevereaplasticanemiatreatedwithallogenicstemcelltransplantationcomparedwithimmunosuppressivetherapyasfirstline
AT isamsharifmohammed p788outcomeofsevereaplasticanemiatreatedwithallogenicstemcelltransplantationcomparedwithimmunosuppressivetherapyasfirstline
AT elhassantusneem p788outcomeofsevereaplasticanemiatreatedwithallogenicstemcelltransplantationcomparedwithimmunosuppressivetherapyasfirstline
AT alzahranihazzaa p788outcomeofsevereaplasticanemiatreatedwithallogenicstemcelltransplantationcomparedwithimmunosuppressivetherapyasfirstline

Ejemplares similares